| John H Hajjar, MD | |
|
631 Grand St, Jersey City, NJ 07304-3451 | |
| (201) 803-2573 | |
| (201) 791-6585 |
| Full Name | John H Hajjar |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 43 Years |
| Location | 631 Grand St, Jersey City, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104894435 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 25MA04215700 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sovereign Medical Group Llc | 1456535392 | 19 |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
The Guardian examines USAID Administrator Rajiv Shah's role in U.S. development policy and looks at some of the domestic challenges he faces.
MonoSol Rx, the developer of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, and APR Applied Pharma Research s.a. ("APR") announced today an expansion of their relationship to identify and develop film formulations of prescription drug products beyond ondansetron and donepezil to include zolmitriptan. Zolmitriptan is currently commercially available for the acute treatment of migraine headache in adults, and facing initial patent expirations in 2012.
The Fondation Leducq in Paris, France, dedicated to improving human health through international efforts to combat cardiovascular disease, awarded a $6 million grant award to a new global research network of cardiovascular scientists which includes three researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai.
A debilitating side effect of a widely used but harshly potent treatment for colon cancer could be eliminated if a promising new laboratory discovery bears fruit.
› Verified 6 days ago
| Entity Name | Sovereign Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710282082 PECOS PAC ID: 1456535392 Enrollment ID: O20110418000519 |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
The Guardian examines USAID Administrator Rajiv Shah's role in U.S. development policy and looks at some of the domestic challenges he faces.
MonoSol Rx, the developer of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, and APR Applied Pharma Research s.a. ("APR") announced today an expansion of their relationship to identify and develop film formulations of prescription drug products beyond ondansetron and donepezil to include zolmitriptan. Zolmitriptan is currently commercially available for the acute treatment of migraine headache in adults, and facing initial patent expirations in 2012.
The Fondation Leducq in Paris, France, dedicated to improving human health through international efforts to combat cardiovascular disease, awarded a $6 million grant award to a new global research network of cardiovascular scientists which includes three researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai.
A debilitating side effect of a widely used but harshly potent treatment for colon cancer could be eliminated if a promising new laboratory discovery bears fruit.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John H Hajjar, MD 680 Kinderkamack Rd Ste 3, Oradell, NJ 07649-1600 Ph: (201) 803-2573 | John H Hajjar, MD 631 Grand St, Jersey City, NJ 07304-3451 Ph: (201) 803-2573 |
News Archive
A team of Netherlands Institute for Neuroscience researchers have found that a restful night with good REM (Rapid Eye Movement) sleep could counteract the effects of unpleasant experiences and memories. They have found the reason behind such an adaptation. Their study titled, "Restless REM sleep impedes overnight amygdale adaptation," was published in the latest issue of the journal Current Biology.
The Guardian examines USAID Administrator Rajiv Shah's role in U.S. development policy and looks at some of the domestic challenges he faces.
MonoSol Rx, the developer of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, and APR Applied Pharma Research s.a. ("APR") announced today an expansion of their relationship to identify and develop film formulations of prescription drug products beyond ondansetron and donepezil to include zolmitriptan. Zolmitriptan is currently commercially available for the acute treatment of migraine headache in adults, and facing initial patent expirations in 2012.
The Fondation Leducq in Paris, France, dedicated to improving human health through international efforts to combat cardiovascular disease, awarded a $6 million grant award to a new global research network of cardiovascular scientists which includes three researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai.
A debilitating side effect of a widely used but harshly potent treatment for colon cancer could be eliminated if a promising new laboratory discovery bears fruit.
› Verified 6 days ago
Elliot Shulman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2255 Kennedy Blvd, Jersey City, NJ 07304 Phone: 201-433-1057 Fax: 201-435-2716 | |
Yale Shulman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2255 John F Kennedy Boulevard, Jersey City, NJ 07304 Phone: 201-433-1057 Fax: 201-435-2716 | |
Dr. John Joseph Hosay Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2555 Kennedy Blvd., Jersey City, NJ 07304 Phone: 201-433-9666 Fax: 201-432-9647 | |
Mr. Joel Abramowitz, Urology Medicare: Accepting Medicare Assignments Practice Location: 142 Palisade Ave, Suite 101, Jersey City, NJ 07306 Phone: 201-656-4104 Fax: 201-656-9178 | |
Elliot Gideon Steigman, MD Urology Medicare: Medicare Enrolled Practice Location: 142 Palisade Ave, Ste 211, Jersey City, NJ 07306 Phone: 201-435-2244 Fax: 201-222-7733 | |
Jose Florante Justiniane Leyson, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 562 Westside Ave, Jersey City, NJ 07304 Phone: 201-434-7800 Fax: 201-434-6715 |